Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Influenza, Human 16Neoplasms 8Leukemia, Lymphocytic, Chronic, B-Cell 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Myelodysplastic Syndromes 4Multiple Myeloma 4Lymphoma 4Leukemia, Myeloid, Acute 4Colorectal Neoplasms 4Lymphoma, Non-Hodgkin 3Leukemia 3Carcinoma, Non-Small-Cell Lung 3Recurrence 2Pancreatic Neoplasms 2Neuroblastoma 2Neoplasms, Plasma Cell 2Melanoma 2Lymphoma, Mantle-Cell 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Hodgkin Disease 2Central Nervous System Neoplasms 2Carcinoma, Renal Cell 2Breast Neoplasms 2Anemia, Aplastic 2Waldenstrom Macroglobulinemia 1Virus Diseases 1Vaccine-Preventable Diseases 1Vaccination Hesitancy 1Triple Negative Breast Neoplasms 1

Interventions

venetoclax 1fludarabine 1Influenza Vaccines 1Decitabine 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Older Patients × Influenza Vaccines × Clear all
NCT07052422 2025-07-04

VEN+DAC+Bu2Flu4 vs Bu2Flu5 Conditioning Regimen for Elderly Myeloid Malignancies Undergoing Allo-HSCT

Nanfang Hospital, Southern Medical University

Phase 2/3 Not yet recruiting
160 enrolled
Other neoplasm

Older Patients

Data powered by HemOnc (CC BY 4.0) Colophon âš¡